Public Employees Retirement Association of Colorado’s Arcutis Biotherapeutics ARQT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$172K Hold
6,577
﹤0.01% 1559
2026
Q1
$155K Hold
6,577
﹤0.01% 1537
2025
Q4
$191K Hold
6,577
﹤0.01% 1498
2025
Q3
$124K Hold
6,577
﹤0.01% 1643
2025
Q2
$92K Hold
6,577
﹤0.01% 1689
2025
Q1
$103K Hold
6,577
﹤0.01% 1665
2024
Q4
$92K Hold
6,577
﹤0.01% 1754
2024
Q3
$61K Buy
+6,577
New +$64.9K ﹤0.01% 1830

Other funds holding ARQT

Public Employees Retirement Association of Colorado's ARQT Position: Q2 2026 in Review

Public Employees Retirement Association of Colorado held its Arcutis Biotherapeutics (ARQT) position steady in Q2 2026 at 6,577 shares worth $172K. The position accounts for ﹤0.01% of the portfolio, ranked #1559.

Public Employees Retirement Association of Colorado first reported a position in ARQT in Q3 2024 and has held it in 8 quarters since. The position peaked at $191K in Q4 2025. 139 funds tracked by Wall St. Rank hold ARQT as of Q2 2026.

  • Public Employees Retirement Association of Colorado held 6,577 shares of Arcutis Biotherapeutics worth $172K as of Q2 2026.
  • Public Employees Retirement Association of Colorado left its Arcutis Biotherapeutics share count unchanged in Q2 2026.
  • Arcutis Biotherapeutics made up ﹤0.01% of Public Employees Retirement Association of Colorado's portfolio in Q2 2026, its #1559 holding.
  • Public Employees Retirement Association of Colorado first reported a position in Arcutis Biotherapeutics in Q3 2024 and has held it in 8 quarters since.
  • Public Employees Retirement Association of Colorado's Arcutis Biotherapeutics position peaked at $191K in Q4 2025.
  • 139 funds tracked by Wall St. Rank held Arcutis Biotherapeutics as of Q2 2026.

Based on Public Employees Retirement Association of Colorado's 13F filing for Q2 2026, filed 11 Aug 2026.